IAIsmael Al-Ramahi

Ismael Al-Ramahi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ismael Al-Ramahi has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SSH1 knockdown increases autophagosome formation through ATG9A recruitment and promotes MAPT/tau protein degradation

    by Morgan C. Stephens, Richard I. Han, Alma M. Perez, Hilary Chester, Maria de Haro, Arsh Ali, Amy Hammett, Ruhee Dere, Ismael Al-Ramahi, Juan Botas

  • Open Access

    MeCP2 interacts with the super elongation complex to regulate transcription

    by Jun Young Sonn, Wonho Kim, Marta Iwanaszko, Yuki Aoi, Yan Li, Guantong Qi, Luke Parkitny, Janice L. Brissette, Lorin Weiner, Juan Botas, et al.

    Loss-of-function mutations in methyl-CpG binding protein 2 ( MECP2 ) cause Rett syndrome. While we know that MeCP2 binds to methylated cytosines on DNA, the full breadth of the molecular mechanisms by which MeCP2 regulates gene expression remains incompletely understood. Here, using a genetic modifier screen, we identify the super elongation complex, a P-TEFb–containing elongation factor that releases promoter-proximally paused RNA polymerase II, as a genetic interactor of MECP2 . MeCP2 physically interacts with SEC subunits and directly binds AFF4, the scaffold of the SEC, via the transcriptional repression domain. Furthermore, MeCP2 facilitates the binding of AFF4 on a subset of genes in the mouse brain regulating synaptic plasticity and concordantly promotes the binding of RNA polymerase II on these genes. Last, while haploinsufficiency of Aff4 does not exhibit any behavioral deficits in mice, it exacerbates the impaired contextual learning behavior of Mecp2 hypomorphic mice. We propose a previously unknown mechanism by which MePC2 regulates gene expression underlying synaptic plasticity.


  • Open Access

    The cytoskeletal protein Plectin regulates Tau‐induced neurotoxicity in Alzheimer’s Disease

    by Tom V Lee, Catherine Chen, Katherine S Allison, Yarong Li, Ismael Al‐Ramahi, Pritha Bagchi, Allan I. Levey, Juan Botas, Nicholas T Seyfried, Joshua M Shulman

    Background: The genetic causes for most cases of Alzheimer’s disease (AD) and the underlying biology of pathogenesis remain unknown. Recent large scale proteomics studies on AD patient brains have identified novel protein networks and targets that are highly correlated with AD diagnosis and neuropathology. The most significantly AD‐correlated protein network identified contains the cytoskeletal protein Plectin (PLEC) as a network hub. PLEC functions to crosslink different cytoskeletal components and plays a role in axonal transport of synaptic proteins. Considering that microtubule associated protein‐Tau (MAPT) dysfunction is an AD hallmark, we hypothesize that PLEC dysfunction increases AD susceptibility by disrupting cytoskeletal homeostasis and synaptic function.Method: Utilizing a combination of genetic and proteomic analyses, we validate Plectin as a potential AD risk factor. We assessed the role of PLEC in Tau‐induced neurotoxicity in the animal model Drosophila melanogaster and human neuronal cell culture. Furthermore, we have also elucidated PLEC mutant neurodegenerative phenotypes independent of Tau overexpression in the fly. Immunoprecipitation‐mass spectrometry (IP‐MS) analysis was performed to define a Drosophila Plectin protein‐protein interaction network in adult brains. This network will serve as the basis for cross‐species analysis of protein networks.Result: The Drosophila homolog of Plectin (dPLEC) is ubiquitously expressed within the adult brain with strong enrichment in neuronal rich tissues. Using Drosophila models of human tauopathy, dPLEC regulates age dependent Tau‐induced neurotoxicity and locomotor dysfunction. Plus, altering levels dPLEC regulates Tau‐phosphorylation in both adult Drosophila brains and human neurons. In the absence of Tau overexpression, dPLEC functions in light‐induced neuronal transmission confirming its role in normal neuronal function. Continued mechanistic analysis in both Drosophila and human neuronal cultures will determine PLEC’s role in AD neuropathogenesis and elucidate the underlying role of the cytoskeleton in AD susceptibility. To that end, we generated an endogenous GFP‐tagged dPLEC (dPLEC‐GFP) and performed immunoprecipitation‐mass spectrometry (IP‐MS) analysis to identify dPLEC protein interactors. Several cytoskeletal and synaptic proteins were identified and are currently being tested for their role in Tau‐induced neurodegeneration and synaptic dysfunction.Conclusion: We functionally validate the AD target PLEC as a regulator of Tau‐induced neurodegeneration and identify PLEC as a regulator of Tau dynamics and neuronal function.


  • Open Access

    Statistical Physics of Fitness Landscapes Finds Risk Genes Specific to Different AD Genetic Backgrounds

    by Yashwanth Lagiesetty, Maryam Samieinasab, Ismael Al‐Ramahi, Kevin Wilhelm, Panagiotis Katsonis, Jenn Asmussen, Kwanghyuk Danny Lee, Juan Botas, Olivier Lichtarge

    Background: To study how genetic backgrounds modulate neurodegenerative risk requires genotype‐phenotype association methods effective in small patient cohorts.Method: We developed a genome sequence analysis framework rooted in Statistical Physics, which yields a reliable measure of gene functional impact in any chosen population. When comparing two populations, such as cases and controls, shifts in gene importance identify those likely to drive phenotype differences.Results: In repeated case‐control genome sequence studies of Alzheimer’s Disease (AD) focused on a single sex, APOE allele, or ethnic ancestry, we identified gene sets that met criteria for success, including prior GWAS studies, post‐mortem of AD brain tissues expression, live Drosophila experiments, and risk modeling.Conclusion: Statistical Physics of fitness landscape is a new tool to characterize genes and mutations that enhance or protect from AD, powerful enough to identify similarities, complementarities, and differences in risk gene in target subgroups of about 1000 subjects.

  • Open Access

    Functional Variants Identify Sex Specific Genes and Pathways in Alzheimer’s Disease

    by Kwanghyuk Danny Lee, Thomas Bourquard, Ismael Al‐Ramahi, Minh Pham, Dillon Shapiro, Yashwanth Lagiesetty, Shirin Soleimani, Samantha Mota, Kevin Wilhelm, Maryam Samieinasab, et al.

    Background: Alzheimer’s Disease (AD) incidence is almost double in women, suggesting sex‐specific risk genes for AD remain to be uncovered.Method: To identify AD risk genes in smaller cohorts of only male or only female subjects we designed a machine learning case‐control study of genome variant differences that included a functional importance score as a feature. The method robustly finds genes in smaller cohorts, enabling us to analyze men and women separately.Result: We found AD‐associated risk genes men‐only, women‐only, or combined subjects. These genes were consistent with a) prior AD GWAS; b) expression in AD patients brain regions; c) transcriptome analyses; d) and in vivo experiments in fly models of Amyloid beta and Tau neurodegeneration. Notably, the sex‐specific genes implicate pathways that are differentially altered in each sex – a stress response pathway unique to AD affected men and cell‐cycle/DNA quality control pathways unique to AD affected women.Conclusion: A machine learning combined with an evolution‐based training feature for variant impact identified common as well as sex‐specific AD‐associated genes and mechanisms of potential value for pre‐symptomatic risk assessment and drug targeting.

  • Open Access

    Modulation of Karyopherin Levels Attenuates Mutant Ataxin-1-Induced Neurodegeneration

    by Elena K Ruff, Dylan Lawrence Timperman, Adulfo Anaya Amador, Isabella Aguirre Lamus, Khondker Salim, Maria de Haro, Ismael Al-Ramahi

    Neurodegenerative diseases are characterized by the abnormal accumulation of disease-driving proteins. Emerging evidence suggests that nucleocytoplasmic transport (NCT) components play a critical role in neurodegeneration. This study investigates the effects of modulating the levels of different karyopherins on mutant Ataxin-1 (mATXN1)-induced neurodegeneration in Spinocerebellar Ataxia Type 1 (SCA1) Drosophila and cell models. Our findings reveal that ATXN1 [82Q] interacts with KPNAs in the nucleus and cytoplasm of neurons. Increasing KPNA levels ameliorates ATXN1 [82Q]-induced neurodegeneration and progressive neuronal dysfunction. Surprisingly, elevated KPNA levels did not increase nuclear mATXN1, instead, mechanistic analyses demonstrate that KPNA retains mATXN1 in the cytoplasm, reducing its nuclear accumulation. Moreover, higher KPNA leads to a decrease in soluble oligomeric mATXN1. Interestingly, inhibition of a different karyopherin, KPNB1, elevated KPNA levels and reduced nuclear mATXN1 in human neuronal precursor cells. Consistently, knockdown of KPNB1 attenuates ATXN1 [82Q]-induced neurodegeneration and reduces its nuclear aggregation in Drosophila . These results indicate that KPNAs may act as chaperones for mutant ATXN1, preventing its nuclear translocation and reducing its pathological effects. Importantly, they also constitute a proof of principle that retaining mATXN1 in the cytoplasm represents an attractive and viable therapeutic option. Given the dysregulation of karyopherins in many neurodegenerative diseases and their emerging role as chaperones, the results presented here may extend beyond SCA1 into other disorders like Alzheimer’s or Parkinson’s disease.


  • Open Access

    Functional variants identify sex-specific genes and pathways in Alzheimer’s Disease

    by Thomas Bourquard, Kwanghyuk Lee, Ismael Al-Ramahi, Minh Pham, Dillon Shapiro, Yashwanth Lagisetty, Shirin Soleimani, Samantha Mota, Kevin Wilhelm, Maryam Samieinasab, et al.

    The incidence of Alzheimer’s Disease in females is almost double that of males. To search for sex-specific gene associations, we build a machine learning approach focused on functionally impactful coding variants. This method can detect differences between sequenced cases and controls in small cohorts. In the Alzheimer’s Disease Sequencing Project with mixed sexes, this approach identified genes enriched for immune response pathways. After sex-separation, genes become specifically enriched for stress-response pathways in male and cell-cycle pathways in female. These genes improve disease risk prediction in silico and modulate Drosophila neurodegeneration in vivo. Thus, a general approach for machine learning on functionally impactful variants can uncover sex-specific candidates towards diagnostic biomarkers and therapeutic targets.


  • Open Access

    Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signalled to DNA damage by Ataxia Telangiectasia Mutated kinase

    by Celeste E. Suart, Alma M. Perez, Ismael Al-Ramahi, Tamara Maiuri, Juan Botas, Ray Truant

    Spinocerebellar Ataxia Type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion in the ataxin-1 protein. Recent genetic correlational studies have implicated DNA damage repair pathways in modifying the age at onset of disease symptoms in SCA1 and Huntington’s Disease, another polyglutamine expansion disease. We demonstrate that both endogenous and transfected ataxin-1 localizes to sites of DNA damage, which is impaired by polyglutamine expansion. This response is dependent on ataxia telangiectasia mutated (ATM) kinase activity. Further, we characterize an ATM phosphorylation motif within ataxin-1 at serine 188. We show reduction of the Drosophila ATM homolog levels in a ATXN1[82Q] Drosophila model through shRNA or genetic cross ameliorates motor symptoms. These findings offer a possible explanation as to why DNA repair was implicated in SCA1 pathogenesis by past studies. The similarities between the ataxin-1 and the huntingtin responses to DNA damage provide further support for a shared pathogenic mechanism for polyglutamine expansion diseases.